Oxy-Gen will provide a comprehensive report based on an individual patient’s genetic makeup that will indicate metabolic rates for defined medications. This information will help clinician’s prescribe the right drug at the right dose based on your DNA profile.
Discover what drugs you take regularly and their relationship between your unique genetic makeup and how you can respond to these certain medications.
According to the FDA, each year, approximately 4.5 million Americans visit their doctors or the emergency room due to everyday drugs you take regularly.
Below you’ll find the various areas where our Pharmacogenomics panel can benefit those taking certain medications for the following conditions.
Pharmacogenomic testing is steadily making progress in the pain management by being able to identify individual differences in the perception of pain and susceptibility and sensitivity to drugs based on genetic markers.
Pharmacogenomic studies of anxiety disorders are mainly focused on pharmacogenetics of antidepressants rather than being anxiety specific. The review focuses different types of anxiety disorders.
Psychiatric pharmacogenomic is providing a third pillar of understanding to better help us prescribe drugs, joining the more well-established pillars of pharmacokinetics and pharmacodynamics.
Cardiovascular pharmacogenomic is the study and identification of genomic markers that are associated with variability in cardiovascular drug response, or cardiovascular drug related adverse events.
Pharmacogenomic test cannot diagnose ADHD, however; they may be a helpful tool for finding practical and personalized medication solutions post initial diagnosis.
©2016-2022 Oxy-Gen Laboratory LLC